DRC Scientist Offers Hope Against New Ebola Outbreak

The Democratic Republic of Congo is fighting an Ebola outbreak with the odds stacked against it, but the scientist leading the response says hope is very much alive.

More than 1,200 people have been infected with the Bundibugyo strain of Ebola across Eastern DRC since May, with 321 deaths reported. Unlike other Ebola strains, no approved vaccine or treatment exists yet for this variant.

But Dr. Jean-Jacques Muyembe, director of the DRC's National Institute of Biomedical Research, brings a message of optimism backed by decades of experience. He co-discovered the Ebola virus in 1976 and has successfully defeated multiple outbreaks without modern treatments.

"There is still hope for this epidemic," Muyembe told reporters. His team is already working with international partners to test existing antiviral molecules that could become treatments within days, not months.

The good news doesn't stop there. The Bundibugyo strain causes less severe illness than other Ebola types, with a fatality rate of 30 to 40 percent compared to higher rates in previous outbreaks.

Muyembe's team previously developed Ebanga, a highly effective treatment for the Zaire strain of Ebola. Now they're partnering with American scientists to create a similar antibody treatment for Bundibugyo.

The Ripple Effect

The response strategy draws on proven public health methods that defeated Ebola long before vaccines existed. Healthcare workers quickly isolate patients, actively search for new cases in communities, and work with families to ensure safe, dignified burials.

This community-centered approach builds trust and breaks transmission chains. Muyembe's team includes family members in funeral processes by providing them protective equipment, allowing them to participate safely while respecting cultural traditions.

The team's previous success with Ebanga shows what's possible when local expertise meets international support. That treatment saved countless lives during the 2018 North Kivu outbreak and subsequent epidemics.

While security challenges and difficult terrain complicate the response, Muyembe remains focused on preparing for the future. He's ensuring Congolese scientists gain experience during each outbreak to build the country's long-term capacity to fight emerging diseases.

The World Health Organization has formed a research group to fast-track testing of promising treatments, combining global resources with local knowledge that only comes from being on the front lines for nearly 50 years.